Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype
Clinical trial NCT00697749 · COMPLETED
Trial details
- NCT number
- NCT00697749
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-04-01
- Primary completion
- 2000-01-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.